Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
September-2020 Volume 20 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2020 Volume 20 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Carbachol protects the intestinal barrier in severe acute pancreatitis by regulating Cdc42/F‑actin cytoskeleton

  • Authors:
    • Hanlin Wang
    • Yingjian Jiang
    • Hongbo Li
    • Jiang Wang
    • Chang Li
    • Dianliang Zhang
  • View Affiliations / Copyright

    Affiliations: Center of Colon and Rectum, Qingdao Municipal Hospital, Qingdao University, Qingdao, Shandong 266011, P.R. China
    Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
  • Pages: 2828-2837
    |
    Published online on: July 10, 2020
       https://doi.org/10.3892/etm.2020.8985
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study aimed to investigate the effect of carbachol on the intestinal tight‑junction barrier in a rat model of severe acute pancreatitis (SAP) without aggravating pancreatic injury, and to determine whether cell division cycle 42 (Cdc42)/F‑actin could have a regulatory role. Rats were separated into a sham‑operation (SO) group (n=10), SO + carbachol group (n=10), SAP group (n=60) and SAP + carbachol group (n=60). Sodium taurocholate (5%) was retrogradely injected into the biliopancreatic duct of rats to induce SAP. Subsequently, 16S rRNA sequencing was used to detect bacterial translocation (BT) in the gut of surviving animals. Hematoxylin and eosin staining was used to detect morphological changes in the pancreas and intestine. The expression of F‑actin and tight junction proteins was analyzed by western blotting and immunofluorescence, and Cdc42 expression was analyzed by immunohistochemistry and western blotting. The results demonstrated that the intestinal injury in SO and SO + carbachol groups was lower than that in the SAP + carbachol group (P<0.05); however, the intestinal injury was similar in the SO and SO + carbachol groups (P>0.05), and was significantly more severe in the SAP group compared with the SAP + carbachol group (P<0.05). Similarly, pancreatic injury in the SAP and SAP + carbachol groups was significantly higher compared with the SO and SO + carbachol groups (P<0.05); however, pancreatic injury was similar in the SAP and SAP + carbachol groups (P>0.05), and in the SO and SO + carbachol groups (P>0.05). Furthermore, the mortality rate and BT in the SAP group were significantly higher compared with the SAP + carbachol group (mortality rate, 50% vs. 30%, P<0.05; BT, 60% vs. 33.3%, P<0.05). In addition, the expression of Cdc42, F‑actin and claudin‑2 was significantly higher in the SAP and SAP + carbachol groups compared with the SO and SO + carbachol groups (P<0.05), and the expression of occludin and zonula occludens‑1 were significantly higher in the SO and SO + carbachol groups compared with the SAP and SAP + carbachol groups (P<0.05). In conclusion, these findings demonstrated that carbachol may protect the intestinal barrier in the SAP rat model without aggravating pancreatic injury via regulation of Cdc42/F‑actin expression.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Leppäniemi A, Tolonen M, Tarasconi A, Segovia-Lohse H, Gamberini E, Kirkpatrick AW, Ball CG, Parry N, Sartelli M, Wolbrink D, et al: 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 14(27)2019.PubMed/NCBI View Article : Google Scholar

2 

Banks PA and Freeman ML: Practice parameters committee of the American college of gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 101:2379–2400. 2006.PubMed/NCBI View Article : Google Scholar

3 

van Dijk SM, Hallensleben NDL, van Santvoort HC, Fockens P, van Goor H, Bruno MJ and Besselink MG: Dutch Pancreatitis Study Group. Acute pancreatitis: Recent advances through randomised trials. Gut. 66:2024–2032. 2017.PubMed/NCBI View Article : Google Scholar

4 

Uhl W, Warshaw A, Imrie C, Bassi C, McKay CJ, Lankisch PG, Carter R, Magno ED, Banks PA, Whitcomb DC, et al: IAP guidelines for the surgical management of acute pancreatitis. Pancreatology. 2:565–573. 2002.PubMed/NCBI View Article : Google Scholar

5 

Berger HG, Rau B, Mayer J and Pralle U: Natural course of acute pancreatitis. World J Surg. 21:130–135. 1997.PubMed/NCBI View Article : Google Scholar

6 

Bradley EL III: A fifteen year experience with open drainage for infected pancreatic necrosis. Surg Gynecol Obstet. 177:215–222. 1993.PubMed/NCBI

7 

Mier J, León EL, Castillo A, Robledo F and Blanco R: Early versus late necrosectomy in severe necrotizing pancreatitis. Am J Surg. 173:71–75. 1997.PubMed/NCBI View Article : Google Scholar

8 

Nieuwenhuijs VB, Besselink MG, van Minnen LP and Gooszen HG: Surgical management of acute necrotizing pancreatitis: A 13-year experience and a systematic review. Scand J Gastroenterol. Suppl:111–116. 2003.PubMed/NCBI View Article : Google Scholar

9 

Werner J, Feuerbach S, Uhl W and Büchler MW: Management of acute pancreatitis: From surgery to interventional intensive care. Gut. 54:426–436. 2005.PubMed/NCBI View Article : Google Scholar

10 

Rau B, Bothe A and Beger HG: Surgical treatment of necrotizing pancreatitis by necrosectomy and closed lavage: Changing patient characteristics and outcome in a 19-year, single-center series. Surgery. 138:28–39. 2005.PubMed/NCBI View Article : Google Scholar

11 

Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG and Vege SS: Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis-2012: Revision of the Atlanta classification and definitions by international consensus. Gut. 62:102–111. 2013.PubMed/NCBI View Article : Google Scholar

12 

Fishman JE, Levy G, Alli V, Zheng X, Mole DJ and Deitch EA: The intestinal mucus layer is a critical component of the gut barrier that is damaged during acute pancreatitis. Shock. 42:264–270. 2014.PubMed/NCBI View Article : Google Scholar

13 

Barbeiro DF, Koike MK, Coelho AM, Pinheiro da Silva F and Machado MC: Intestinal barrier dysfunction and increased COX-2 gene expression in the gut of elderly rats with acute pancreatitis. Pancreatology. 16:52–56. 2016.PubMed/NCBI View Article : Google Scholar

14 

Simsek I, Mas MR, Yasar M, Ozyurt M, Saglamkaya U, Deveci S, Comert B, Basustaoglu A, Kocabalkan F and Refik M: Inhibition of inducible nitric oxide synthase reduces bacterial translocation in a rat model of acute pancreatitis. Pancreas. 23:296–301. 2001.PubMed/NCBI View Article : Google Scholar

15 

Schwarz M, Poch B, Isenmann R, Kriese D, Rozdzinski E, Beger HG and Gansauge F: Effect of early and late antibiotic treatment in experimental acute pancreatitis in rats. Langenbecks Arch Surg. 392:365–370. 2007.PubMed/NCBI View Article : Google Scholar

16 

Schmid SW, Uhl W, Friess H, Malfertheiner P and Büchler MW: The role of infection in acute pancreatitis. Gut. 45:311–316. 1999.PubMed/NCBI View Article : Google Scholar

17 

Medich DS, Lee TK, Melhem MF, Rowe MI, Schraut WH and Lee KK: Pathogenesis of pancreatic sepsis. Am J Surg. 165:46–52. 1993.PubMed/NCBI View Article : Google Scholar

18 

Wang J, Li C, Jiang YJ, Zheng HM, Li DH, Liang YB, Deng WS and Zhang DL: Effect of ceramide-1-phosphate transfer protein on intestinal bacterial translocation in severe acute pancreatitis. Clin Res Hepatol Gas. 41:86–92. 2017.PubMed/NCBI View Article : Google Scholar

19 

Deng WS, Zhang J, Ju H, Zheng HM, Wang J, Wang S and Zhang DL: Arpin contributes to bacterial translocation and development of severe acute pancreatitis. World J Gastroenterol. 21:4293–4301. 2015.PubMed/NCBI View Article : Google Scholar

20 

Buckley A and Turner JR: Cell biology of tight junction barrier regulation and mucosal disease. Cold Spring Harb Perspect Biol. 10(a029314)2018.PubMed/NCBI View Article : Google Scholar

21 

Dokladny K, Zuhl MN and Moseley PL: Intestinal epithelial barrier function and tight junction proteins with heat and exercise. J Appl Physiol (1985). 120:692–701. 2016.PubMed/NCBI View Article : Google Scholar

22 

Anderson JM and Van Itallie CM: Physiology and function of the tight junction. Cold Spring Harb Perspect Biol. 1(a002584)2009.PubMed/NCBI View Article : Google Scholar

23 

Doherty GJ and McMahon HT: ‘Mediation, modulation, and consequences of membrane-cytoskeleton interactions’. Annu Rev Biophys. 37:65–95. 2008.PubMed/NCBI View Article : Google Scholar

24 

Qadir MI, Parveen A and Ali M: Cdc42: Role in cancer management. Chem Biol Drug Des. 86:432–439. 2015.PubMed/NCBI View Article : Google Scholar

25 

Cao WH, Chai JK, Hu S, Yang H, Sun T, Zou X and Sheng Z: Influence of carbachol on intestinal dysfunction after traumatic or burn injury. Zhonghua Shao Shang Za Zhi. 22:168–171. 2006.PubMed/NCBI(In Chinese).

26 

Khan MR, Uwada J, Yazawa T, Islam MT, Krug SM, Fromm M, Karaki S, Suzuki Y, Kuwahara A, Yoshiki H, et al: Activation of muscarinic cholinoceptor ameliorates tumor necrosis factor-a-induced barrier dysfunction in intestinal epithelial cells. FEBS Lett. 589:3640–3647. 2015.PubMed/NCBI View Article : Google Scholar

27 

Zhang Y and Li J: Carbachol ameliorates lipopolysaccharide-induced intestinal epithelial tight junction damage by down-regulating NF-κβ and myosin light-chain kinase pathways. Biochem Biophys Res Commun. 428:321–326. 2012.PubMed/NCBI View Article : Google Scholar

28 

Xu W, Zhou YF and Xia SH: Octreotide for primary moderate to severe acute pancreatitis: A meta-analysis. Hepatogastroenterology. 60:1504–1508. 2013.PubMed/NCBI

29 

Li J, Wang R and Tang C: Somatostatin and octreotide on the treatment of acute pancreatitis-basic and clinical studies for three decades. Curr Pharm Des. 17:1594–1601. 2011.PubMed/NCBI View Article : Google Scholar

30 

Huang L, Jiang Y, Sun Z, Gao Z, Wang J and Zhang D: Autophagy strengthens intestinal mucosal barrier by attenuating oxidative stress in severe acute pancreatitis. Dig Dis Sci. 63:910–919. 2018.PubMed/NCBI View Article : Google Scholar

31 

Schmidt J, Rattner DW, Lewandrowski K, Compton CC, Mandavilli U, Knoefel WT and Warshaw AL: A better model of acute pancreatitis for evaluating therapy. Ann Surg. 215:44–56. 1992.PubMed/NCBI View Article : Google Scholar

32 

Chiu CJ, McArdle AH, Brown R, Scott HJ and Gurd FN: Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg. 101:478–483. 1970.PubMed/NCBI View Article : Google Scholar

33 

Amasheh S, Dullat S, Fromm M, Schulzke JD, Buhr HJ and Kroesen AJ: Infamed pouch mucosa possesses altered tight junctions indicating recurrence of infammatory bowel disease. Int J Colorectal Dis. 24:1149–1156. 2009.PubMed/NCBI View Article : Google Scholar

34 

Shi C, Ren L, Sun C, Yu L, Bian X, Zhou X, Wen Y, Hua D, Zhao S, Luo W, et al: miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients. Br J Cancer. 117:1036–1047. 2017.PubMed/NCBI View Article : Google Scholar

35 

Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J and Koki AJ: Cox-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer. 89:2637–2645. 2000.PubMed/NCBI View Article : Google Scholar

36 

Remmele W and Schicketanz KH: Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer Computer-assisted image analysis (QIC score) vs. subjective grading (IRS). Pathol Res Pract. 189:862–866. 1993.PubMed/NCBI View Article : Google Scholar

37 

Werge M, Novovic S, Schmidt PN and Gluud LL: Infection increases mortality in necrotizing pancreatitis: A systematic review and meta-analysis. Pancreatology. 16:698–707. 2016.PubMed/NCBI View Article : Google Scholar

38 

Nagpal K, Minocha VR, Agrawal V and Kapur S: Evaluation of intestinal mucosal permeability function in patients with acute pancreatitis. Am J Surg. 192:24–28. 2006.PubMed/NCBI View Article : Google Scholar

39 

Ammori BJ, Leeder PC, King RF, Barclay GR, Martin IG, Larvin M and McMahon MJ: Early increase in intestinal permeability in patients with severe acute pancreatitis: Correlation with endotoxemia, organ failure, and mortality. J Gastrointest Surg. 3:252–262. 1999.PubMed/NCBI View Article : Google Scholar

40 

Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ, Riecken EO and Schulzke JD: Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology. 116:301–309. 1999.PubMed/NCBI View Article : Google Scholar

41 

Ma TY: Intestinal epithelial barrier dysfunction in Crohn's disease. Proc Soc Exp Biol Med. 214:318–327. 1997.PubMed/NCBI View Article : Google Scholar

42 

Jiang Y, Lin J, Zhang D, Yu Z, Li Q, Jiang J and Li J: Bacterial translocation contributes to cachexia and its possible pathway in patients with colon cancer. J Clin Gastroenterol. 48:131–137. 2014.PubMed/NCBI View Article : Google Scholar

43 

Paran H, Mayo A, Paran D, Neufeld D, Shwartz I, Zissin R, Singer P, Kaplan O, Skornik Y and Freund U: Octreotide treatment in patients with severe acute pancreatitis. Digest Dis Sci. 45:2247–2251. 2000.PubMed/NCBI View Article : Google Scholar

44 

Uhl W, Buchler MW, Malfertheiner P, Beger HG, Adler G and Gaus W: A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut. 45:97–104. 1999.PubMed/NCBI View Article : Google Scholar

45 

Mckay C, Baxter J and Imrie C: A randomized, controlled trial of octreotide in the management of patients with acute pancreatitis. Int J Pancreatol. 21:13–19. 1997.PubMed/NCBI View Article : Google Scholar

46 

Bhatia M: Apoptosis versus necrosis in acute pancreatitis. Am J Physiol Gastrointest Liver Physiol. 286:G189–G196. 2004.PubMed/NCBI View Article : Google Scholar

47 

Chen Y, Chong MM, Darwiche R, Thomas HE and Kay TW: Severe pancreatitis with exocrine destruction and increased islet neogenesis in mice with suppressor of cytokine signaling-1 deficiency. Am J Pathol. 165:913–921. 2004.PubMed/NCBI View Article : Google Scholar

48 

Feng Y, Wang Y, Wang P, Huang Y and Wang F: Short-chain fatty acids manifest stimulative and protective effects on intestinal barrier function through the inhibition of NLRP3 inflammasome and autophagy. Cell Physiol Biochem. 49:190–205. 2018.PubMed/NCBI View Article : Google Scholar

49 

Zhao J, Zhao R, Cheng L, Yang J and Zhu L: Peroxisome proliferator-activated receptor gamma activation promotes intestinal barrier function by improving mucus and tight junctions in a mouse colitis model. Dig Liver Dis. 50:1195–1204. 2018.PubMed/NCBI View Article : Google Scholar

50 

Ma L, Rohatgi R and Kirschner MW: The Arp2/3 complex mediates actin polymerization induced by the small GTP-binding protein Cdc42. Proc Natl Acad Sci. 95:15362–15367. 1998.PubMed/NCBI View Article : Google Scholar

51 

Rohatgi R, Ma L, Miki H, Lopez M, Kirchhausen T, Takenawa T and Kirschner MW: The interaction between NWASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell. 97:221–231. 1999.PubMed/NCBI View Article : Google Scholar

52 

Hall A: Small GTP-binding proteins and the regulation of the actin cytoskeleton. Annu Rev Cell Biol. 10:31–54. 1994.PubMed/NCBI View Article : Google Scholar

53 

Nobes CD and Hall A: Rho, Rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell. 81:53–62. 1995.PubMed/NCBI View Article : Google Scholar

54 

Ren X, Zhu Y, Gamallat Y, Ma S, Chiwala G, Meyiah A and Xin Y: E. coli O124 K72 alters the intestinal barrier and the tight junctions proteins of guinea pig intestine. Biomed Pharmacother. 94:468–473. 2017.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang H, Jiang Y, Li H, Wang J, Li C and Zhang D: Carbachol protects the intestinal barrier in severe acute pancreatitis by regulating Cdc42/F‑actin cytoskeleton. Exp Ther Med 20: 2828-2837, 2020.
APA
Wang, H., Jiang, Y., Li, H., Wang, J., Li, C., & Zhang, D. (2020). Carbachol protects the intestinal barrier in severe acute pancreatitis by regulating Cdc42/F‑actin cytoskeleton. Experimental and Therapeutic Medicine, 20, 2828-2837. https://doi.org/10.3892/etm.2020.8985
MLA
Wang, H., Jiang, Y., Li, H., Wang, J., Li, C., Zhang, D."Carbachol protects the intestinal barrier in severe acute pancreatitis by regulating Cdc42/F‑actin cytoskeleton". Experimental and Therapeutic Medicine 20.3 (2020): 2828-2837.
Chicago
Wang, H., Jiang, Y., Li, H., Wang, J., Li, C., Zhang, D."Carbachol protects the intestinal barrier in severe acute pancreatitis by regulating Cdc42/F‑actin cytoskeleton". Experimental and Therapeutic Medicine 20, no. 3 (2020): 2828-2837. https://doi.org/10.3892/etm.2020.8985
Copy and paste a formatted citation
x
Spandidos Publications style
Wang H, Jiang Y, Li H, Wang J, Li C and Zhang D: Carbachol protects the intestinal barrier in severe acute pancreatitis by regulating Cdc42/F‑actin cytoskeleton. Exp Ther Med 20: 2828-2837, 2020.
APA
Wang, H., Jiang, Y., Li, H., Wang, J., Li, C., & Zhang, D. (2020). Carbachol protects the intestinal barrier in severe acute pancreatitis by regulating Cdc42/F‑actin cytoskeleton. Experimental and Therapeutic Medicine, 20, 2828-2837. https://doi.org/10.3892/etm.2020.8985
MLA
Wang, H., Jiang, Y., Li, H., Wang, J., Li, C., Zhang, D."Carbachol protects the intestinal barrier in severe acute pancreatitis by regulating Cdc42/F‑actin cytoskeleton". Experimental and Therapeutic Medicine 20.3 (2020): 2828-2837.
Chicago
Wang, H., Jiang, Y., Li, H., Wang, J., Li, C., Zhang, D."Carbachol protects the intestinal barrier in severe acute pancreatitis by regulating Cdc42/F‑actin cytoskeleton". Experimental and Therapeutic Medicine 20, no. 3 (2020): 2828-2837. https://doi.org/10.3892/etm.2020.8985
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team